Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

41.32USD
12 Dec 2018
Change (% chg)

$0.52 (+1.27%)
Prev Close
$40.80
Open
$41.08
Day's High
$42.12
Day's Low
$40.75
Volume
289,357
Avg. Vol
212,270
52-wk High
$96.51
52-wk Low
$35.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 10.71 -1.263
Jun '18 25.18 2.071
Mar '18 15.68 -1.252
FY 2017 Dec '17 7.41 -1.745
Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 18 30.25 59.80 11.40 42.85
Quarter Ending Mar-19 11 21.31 36.20 11.65 44.57
Year Ending Dec-18 20 81.27 119.89 60.90 94.54
Year Ending Dec-19 20 110.40 157.06 65.24 259.44
Earnings (per share)
Quarter Ending Dec-18 20 -1.03 -0.12 -1.79 -1.15
Quarter Ending Mar-19 11 -1.21 -0.80 -1.70 -0.98
Year Ending Dec-18 17 -1.49 -0.43 -3.40 -5.56
Year Ending Dec-19 21 -4.54 -1.69 -6.40 -1.96
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 153.83 49.58 6.22
Price to Book (MRQ) 11.96 10.17 5.20
Price to Tangible Book (MRQ) 13.80 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 83.26 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.10 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -3.39 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.91 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -116.29 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.58

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 6.09 3.44 3.10
LT Debt to Equity (MRQ) 0.47 18.69 11.49
Total Debt to Equity (MRQ) 0.60 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -816.79 -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -984.26 -184.99 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -973.11 -175.75 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -962.76 -182.49 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,602 7,649,007 873,056,423
Net Income/Employee (TTM) -920,417 653,334 103,484,349
Receivable Turnover (TTM) 6.52 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.06 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.26 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -61.15 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -63.88 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.35 2.68 99 98
13 Week 41.42 34.53 99 94
26 Week 71.05 58.05 99 98
52 Week 44.55 22.52 99 68
YTD 75.23 53.89 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 266
Total Shares Held: 40,208,350
3 Mo. Net Change: 692,610
# New Positions: 30
# Closed Positions: 27
# Increased Positions: 116
# Reduced Positions: 101
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.